The efficacy of antenatal Cognitive Behavioural Therapy for antenatal and postnatal depression: A PRISMA based systematic review and meta-analysis

Dooley, R. L., & McAloon, J. (2025). The efficacy of antenatal cognitive Behavioural therapy for antenatal and postnatal depression: A PRISMA based systematic review and meta-analysis. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.02.008

Summary by: Ana Melissa Caballero Pasquini

This study emphasizes the potential risks and effective treatments of depression during the antenatal and postnatal period of pregnancy, considering it is a period of ongoing hormonal changes. Antenatal depression usually increases risk for mothers and children, including obstetrics and neonatal complications, difficulty in mother-infant attachment, and the development of depression after birth. However, its severity can vary during the perinatal period, raising the questions of whether antenatal depression and postnatal depression should be considered as two different conditions of affective illness. Considering that Cognitive Behavioral Therapy has been widely used to aid symptoms of depression, this study aimed to investigate the effectiveness of this therapy during the antenatal period and postnatal period. The study also aims to examine delivery format, treatment facilitator, location, outcome measures, age, gestation, parity, and symptom severity as factors that influence the effectiveness of CBT treatment.

By using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines,  studies with pregnant female participants from 2000-2023 were chosen based on whether they experienced clinical levels of depression and were receiving CBT treatment for affective or depressive symptoms with control groups based on a non-clinical intervention. It included studies with psychometric assessments of depression before, during, or within 12 months of birth. While those studies that portrayed clinical comorbidities were excluded. The risk of bias was assessed with the help of the Cochrane Risk of Bias Tool Version 2. The data extracted from studies included: intervention type, sample size and mean participant age, mean gestation week, inclusion criteria, participant demographics, and outcome measures. The following statistical analyses were utilized:  Comprehensive Meta-Analysis Version 3, random effects models, meta-regressions and subgroup analyses.

The study found that CBT delivered during pregnancy significantly reduced symptoms of depression experienced in the antenatal period, and up to 12 months in the postnatal period in between and within group analyses. Nevertheless, the effectiveness of symptom reduction was higher for those in the antenatal period. The following variables were found to be moderators for treatment outcomes in both the antenatal and postnatal periods: maternal age, number of weeks of gestation, multiparity, marital status, and almost all psychometric assessment measures. The following variables were found to be less consistent when moderating treatment effectiveness: facilitator of treatment, treatment delivery mode, outcome measure, and symptom severity. Meanwhile, only the delivery of treatment by mental health professionals seems to moderate treatment outcomes in the postnatal period.

This study demonstrates that Cognitive Behavioral Therapy has benefits for treating depression in both the antenatal and postnatal periods. It serves as a guidance for future practitioners to utilize CBT especially during the antenatal period, considering its higher effectiveness compared to the postnatal period benefits. The study also suggests the identification of depression in the antenatal period to be distinct from the postnatal period. It also contributes to the specific moderators that influence treatment outcomes. However, more research utilizing larger samples and active control groups could be beneficial, as well as exploration of how specific moderators impact pregnancy.

Cognitive behavioral therapy for insomnia: A meta-analysis of long-term eff ects in controlled studies

Van Der Zweerde, T., Bisdounis, L., Kyle, S. D., Lancee, J., & Van Straten, A. (2019). Cognitive behavioral therapy for insomnia: A meta-analysis of long-term effects in controlled studies. Sleep Medicine Reviews, 48, 101208. https://doi.org/10.1016/j.smrv.2019.08.002

Summary by: Isabel Nemeth

According to the DSM-IV, insomnia can be defined as, “a persistent difficulty initiating or maintaining sleep, for three months or longer and for at least three nights a week, resulting in impaired daytime functioning and signifi cant distress” (van der Zweerde et al., 2019). Only 6% of the general population suff ers from insomnia, but around 30% experience the symptoms of insomnia without meeting the criteria for diagnosis in the DSM-IV (Morin et al., 2006; Ohayon, 2002). If untreated, insomnia may persist for years and have an eff ect on daily life in aspects such as, mood, fatigue, cognitive ability, physical well-being, and social relationships. (Kyle et al., 2010; Morin et al., 2009).

Cognitive behavioral therapy (CBT) has already proven to be an effective treatment for insomnia in the short term. In fact, oftentimes it is the preferred treatment method over pharmacotherapy according to the American and European guidelines (Qaseem et al., 2016; Riemann et al., 2017). This is because of the potential risks that sleep medication constitutes for the patient long-term for instance, dizziness, drowsiness, addiction, and relapse when the medication is discontinued (Buscemi et al., 2007; Riemann et al., 2017). Furthermore, the lack of suffi cient evidence on the long-term eff ects of pharmacotherapy poses additional problems when it comes to prescribing. Following this information, cognitive behavioral therapy for insomnia (CBT-I) is assumed to be the better treatment option for long-term (Riemann et al., 2017).

With that being said, the researchers of the present meta-analysis don’t know of any meta-analyses published that included controlled studies on the long-term eff ects of CBT-I on patients. van der Zweerde and her colleagues aim to address this gap in the literature and include all available randomized control trials (RCT) reporting on the controlled long-term eff ects of CBT-I at 3, 6, and 12 months and quantifying these eff ects (van der Zweerde et al., 2019).

The focus of the present meta-analysis was on subjective sleep outcomes according to accounts of sleep diaries and self-reported symptoms. The researchers used their previous meta-analysis as a starting point and checked whether any of those studies had published follow-up measurements or data since then. Subsequently, they performed a new search that covered the period of time from the end of the previous search (December 2015) to May 2018 (van der Zweerde et al., 2019). The inclusion criteria were the following: RCT design, investigation of CBT-I or its components, adult participants, self-reported or formally diagnosed insomnia, the comparison to a non-active control group, inclusion of sleep diary outcomes,

reporting of follow-up data for 12 or more weeks post test, and the provision of suitable data for eff ect size calculation (van der Zweerde et al., 2019). The CBT-I components were defi ned as relaxation therapy (RE), sleep restriction therapy (SRT), stimulus control therapy (SC), paradoxical intention (PI), and cognitive therapy (CT) (van der Zweerde et al., 2019).

This study was focused primarily on insomnia severity which was measured through questionnaires (ISI), and secondarily on sleep onset latency (SOL) and sleep effi ciency (SE) measured through sleep diaries. The data extraction process involved coding characteristics such as publication year, recruitment setting, insomnia defi nition, comorbidity, age group, treatment format, number of sessions, control group type, and intervention type. Lastly, the statistical analysis involved computing Hedges’ g for eff ect sizes, using a random eff ects model to account for heterogeneity, and checking for outliers and publication bias (van der Zweerde et al., 2019).

The fi nal meta-analysis included 29 studies after excluding one outlier. The results showed that CBT-I had signifi cant eff ects on insomnia severity at 3, 6, and 12 months with eff ect sizes declining over time (large at 3 months, moderate at 6 months, small at 12 months). The researchers found that three months after treatment, the severity of insomnia complaints (primary outcome) was better for patients treated with CBT-I than for patients without the active treatment. Additionally, signifi cant eff ects were observed for SE and SOL at 3, 6, and 12 months (van der Zweerde et al., 2019).

In general, there was a steady decline overtime of the long-term eff ects of CBT-I. This indicates that the long-term eff ects of CBT-I are smaller than the eff ects seen in the short-term. There are several factors we have to consider when analyzing these results. The analyses at the diff erent time points include diff erent studies which could lead to biased eff ect size estimates. Furthermore, patients in the control conditions could start sleeping better over time either because they have sought treatment elsewhere or purely as a result of time passing. As the time of follow-up increases, so does the time frame of opportunity to seek treatment elsewhere. Finally, when looking at the data for the individual studies included in the present meta-analysis, participants reported a return of symptoms over time. This could be because the interventions are relatively short and focus on behavioral changes such as lifestyle, bedtimes, and sleep hygiene (van der Zweerde et al., 2019).

A randomized controlled trial comparing EMDR and CBT for OCD

 

Marsden, Z., Lovell, K., Blore, D., Ali, S., & Delgadillo, J. (2017). A randomized controlled trial comparing EMDR and CBT for obsessive–compulsive disorder. Clinical Psychology & Psychotherapy, 25(1). https://doi.org/10.1002/cpp.2120

Summary by: Swastika Dutta Gupta

The study by Marsden et al. (2018) investigates and compares the effectiveness of Cognitive Behavioral Therapy (CBT) and Eye Movement Desensitization and Reprocessing (EMDR) in treating Obsessive-Compulsive Disorder (OCD). CBT, especially when using Exposure and Response Prevention (ERP), is widely recognized as the most evidence-based and effective treatment for OCD.

However, the study raises an important question: could EMDR, a therapy primarily used for trauma, offer comparable or complementary benefits for people with OCD—especially those with underlying trauma?

The researchers worked with 55 participants diagnosed with OCD, randomly assigning them to either a CBT group or an EMDR group. Each group received 16 sessions of therapy. For the CBT group, sessions followed the traditional ERP approach, gradually exposing individuals to feared situations while preventing the compulsive responses. The EMDR group followed a standard protocol aimed at processing distressing or traumatic memories that may have contributed to the OCD symptoms.

Results from the study showed that both CBT and EMDR led to improvements in OCD symptoms, as well as reductions in anxiety and depression. However, the CBT group showed significantly greater reductions in OCD symptom severity, as measured by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), both immediately post-treatment and at follow-up. This reinforced CBT’s position as the most effective standalone therapy for OCD. However, EMDR still showed promise—particularly for individuals whose obsessions and compulsions seemed to be linked to past emotionally charged experiences.

One of the most interesting aspects of the study is the way it challenges a rigid distinction between “trauma therapy” and “OCD therapy.” By suggesting that certain OCD cases may have trauma-related origins, the authors open up a space for more nuanced, individualized treatment planning. They propose that EMDR might be a useful supplementary or alternative method for people who struggle with or don’t fully respond to CBT.

The study also raises questions for future research. For example, how can clinicians best identify whether a person’s OCD has trauma-based origins? Could a combined approach of CBT and EMDR improve outcomes even further? While the sample size was relatively small, the randomized controlled design gives the findings weight and encourages clinicians to consider flexibility in treatment rather than rigid adherence to one approach.

Overall, the study confirms CBT’s superior efficacy for OCD while inviting us to explore EMDR’s role more deeply in complex or comorbid cases.

Effectiveness and Acceptability of Third-Wave eHealth Treatments: A Meta-Analysis

O’Connor, M., Munnelly, A., Whelan, R., & McHugh, L. (2018). The efficacy and acceptability of third-wave behavioral and cognitive eHealth treatments: A systematic review and meta-analysis of randomized controlled trials. Behavior Therapy, 49(3), 459–475. https://doi.org/10.1016/j.beth.2017.07.007

Summary by: Benedikt Luther

According to a report by the European Parliamentary Research Service, an estimated 84 million people in the European Union (EU) currently suffer from mental health problems (Amand-Eeckhout, 2023). This corresponds to almost one in five EU citizens and is equivalent to the entire population of Germany. Additionally, mental health problems carry negative social and economic consequences, such as job loss, family issues, and decreased social participation, all of which may worsen mental health crises—a vicious cycle. Access to professional mental healthcare is not equally guaranteed for everyone. eHealth applications represent one way for improving access to mental health services, particularly when traditional face-to-face therapy is limited by geographic, economic, or social barriers. However, questions remain regarding how these digital interventions are accepted and how effective they are.

O’Connor et al. (2018) examined in a systematic review and meta-analysis the efficacy and acceptability of digital interventions based on so-called "third-wave" therapies, including for example Acceptance and Commitment Therapy (ACT) and Mindfulness-Based Cognitive Therapy (MBCT). The authors define eHealth broadly as “an innovative method of delivering therapeutic content with the potential to improve access to third-wave behaviural [sic!] and cognitive therapies” (O’Connor et al., 2018, p. 459). The meta-analysis included 21 studies using randomized controlled trials with a total of N = 3,176 participants. The interventions primarily targeted to improve anxiety, depression, and quality of life. The meta-analysis found small to medium positive effects for the reduction of anxiety (g = 0.32, 95 % CI [0.09, 0.56], p = .01) and depression (g = 0.52, 95 % CI [0.26, 0.77], p < .001), compared to inactive control groups. Additionally, quality of life significantly improved under these conditions (g = 0.46, 95 % CI [0.00, 0.92], p = .05) However, compared to active control conditions, the significant effects were smaller in magnitude (O’Connor et al., 2018). The differences in the outcomes anxiety (g = 0.31, 95 % CI [0.07, 0.54], p = .01); depression (g = 0.29, 95 % CI [0.14, 0.44], p < .001); quality-of-life differences were nonsignificant (g = 0.31, 95 % CI [- 0.31, 0.93], p = .33) Furthermore, digital third-wave interventions showed no significant differences in efficacy compared to other established psychotherapeutic treatments, anxiety (g = 0.00, 95 % CI [-0.16, 0.17], p = .97), depression (g = -0.02, 95 % CI [-0.18, 0.15], p = .83), and quality of life (g = 0.22, 95 % CI [-0.21, 0.65], p = .31). This suggests that eHealth programs could serve as viable alternatives. Importantly, there were no significant differences in attrition rate between inactive controls (OR = 1.24, 95 % CI [0.82, 1.86], p = .30), active controls (OR = 1.03, 95 % CI [0.63, 1.66], p = .92), or comparison interventions (OR = 1.03, 95 % CI [0.79, 1.33], p = .84) That indicates good acceptance of digital formats (O’Connor et al., 2018).

Nevertheless, several limitations remain noteworthy. The authors note that access to eHealth may depend on the digital divide (O’Connor et al., 2018). That means that digital offers are not equally accessible to everyone, particularly for vulnerable populations facing socioeconomic disadvantages such as children or individuals dealing with homelessness. Thus, eHealth interventions alone may not fully break the vicious cycle described earlier. That highlights the importance of considering these vulnerable groups explicitly during program design. Additionally, because the meta-analysis drew studies exclusively from peer-reviewed, English-language journals, results are potentially subject to publication bias. It should also be mentioned that the results should not be generalized to children and adolescents, as they were not part of the meta-analysis (O’Connor et al., 2018). Furthermore, it is critical to mention that the study data are relatively old, covering studies published between 2007 and 2015. Given the technological advancements since then, eHealth programs likely have evolved substantially.

To conclude, eHealth interventions are effective and widely accepted by users. Patients do not tend to discontinue these interventions more frequently than face-to-face therapies. However, under certain conditions, eHealth alternatives are not as effective as traditional face-to-face interventions. Nonetheless, eHealth programs offer scalable, costeffective opportunities for broad dissemination (O’Connor et al., 2018). Future initiatives must particularly consider vulnerable groups with lower socioeconomic status and provide targeted support to ensure equity in mental healthcare access.

Dialectical behaviour therapy v. mentalisation-based therapy for borderline personality disorder

Barnicot, K., & Crawford, M. (2019). Dialectical behaviour therapy v. mentalisation-based therapy for borderline personality disorder. Psychological Medicine, 49(12), 2060–2068. https://doi.org/10.1017/S0033291718002878

Summary by: Hadija Satel

Introduction: Borderline Personality Disorder (BPD) is a mental health condition that involves emotional instability, self-harm, problems in relationships, and frequent use of emergency or hospital services. Two therapies that are commonly used to treat BPD are Dialectical Behaviour Therapy (DBT) and Mentalisation-Based Therapy (MBT). While both treatments have strong evidence supporting their effectiveness, there has never been a direct comparison between the two. The 2019 study by Barnicot and Crawford, published in Psychological Medicine aimed to examine how DBT and MBT compare in terms of clinical outcomes over a 12-month period.DBT is a therapy that focuses on teaching practical skills to manage emotions, reduce self-harm, and improve relationships. It combines cognitive-behavioural methods with mindfulness. MBT, focuses on helping patients understand their own and others' mental states more clearly. This process is called mentalizing. While DBT is usually delivered over 12 months, MBT often lasts around 18 months, but for the purpose of this study, both treatments were evaluated over the same 12-month period.

Method: The study included 90 adults diagnosed with BPD. 58 participants received DBT and 32 participants received MBT in six specialist NHS personality disorder services in London and Southampton. The allocation of participants was not randomized. The choice of therapy was based on what was available in each local service. This approach demonstrated real-life practice but also meant there were some differences in the patient groups. At the beginning of the study,the researchers saw that people in the DBT group tended to have more severe symptoms. They were more likely to have self-harmed recently, had more frequent hospital visits, and higher rates of post-traumatic stress disorder (PTSD). They also showed higher levels of emotional dysregulation. These differences were important and were taken into account in the statistical analysis. Throughout the 12-month period, participants were assessed every three months. The study measured how many people dropped out of therapy, how often they used crisis services, how often they self-harmed, and their levels of BPD symptoms, emotional dysregulation, dissociation, and interpersonal difficulties.

Results: The results showed that both DBT and MBT helped reduce symptoms of BPD. At the end of the 12 months, there were no significant differences between the two groups in terms of self-harm rates, emotional dysregulation, BPD severity, or relationship difficulties. This means that both treatments appeared to be similarly effective by the end of the year. However, when looking at how quickly patients improved over time, there were important differences. People receiving DBT had a steeper reduction in self-harm incidents and faster improvements in emotional dysregulation than those receiving MBT. These findings remained significant even after adjusting for differences in baseline severity, dropout rates, and other confounding factors. This suggests that while both therapies work, DBT may help patients improve more quickly in reducing self-harming behavior and improving emotional control.The study also found differences in treatment dropout. A larger percentage of MBT patients (72%) completed the full 12 months of therapy compared to DBT patients (42%). However, once the researchers adjusted for initial differences between the groups, this difference in completion rates was no longer statistically significant. The higher dropout rate in DBT may be partly explained by the fact that patients starting DBT had more severe symptoms and may have had more difficulty staying engaged. Interestingly, while DBT patients initially seemed to use crisis services more often, these differences disappeared once the analysis controlled for the more severe starting point of the DBT group. In other words, DBT patients may not have used crisis services more because of the therapy itself, but because they were already more at risk before starting treatment.

Discussion: The study has several strengths. It was conducted in real-world clinical settings with actual NHS services, making the results relevant to everyday practice. It also included people who dropped out of treatment, which gives a more complete picture of how the therapies perform in practice. The researchers adjusted for initial differences between the two groups. However, there were some limitations. Since patients were not randomly assigned to DBT or MBT, it’s possible that unknown factors influenced the results. Also, the study only followed patients for 12 months, while BPD is a long-term condition that may require longer follow-up to fully understand treatment effects. Another limitation was that the researchers did not assess how closely the therapists followed the official DBT or MBT manuals, which could affect how effective the treatments were.

In conclusion, this study found that both DBT and MBT are helpful for people with BPD. however there were differences such as DBT appeared to produce faster improvements in reducing self-harm and emotional dysregulation. MBT, on the other hand, may have better retention rates. These results show  that both treatments have their strengths, and choosing between them might depend on the individual needs of the patient, such as their level of risk or ability to stay engaged in long-term therapy. This study also shows the importance of offering a variety of evidence-based treatments within mental health services, so that patients with BPD can receive care that best fits their circumstances. While more research, especially randomised trials is still needed, this comparison gives useful guidance for clinicians and services when deciding which therapy to offer.

Changes in Trauma-Related Emotions Following DBT-PTSD in Survivors of Childhood Abuse

Görg, N., Böhnke, J. R., Priebe, K., Rausch, S., Wekenmann, S., Ludäscher, P., Bohus, M., & Kleindienst, N. (2019). Changes in Trauma‐Related Emotions following treatment with Dialectical Behavior therapy for posttraumatic stress Disorder after childhood abuse. Journal of Traumatic Stress, 32(5), 764–773. https://doi.org/10.1002/jts.22440

Summary by: Alma Aldema

Introduction

I’ll start by highlighting why this study matters. PTSD isn't just about fear, it also involves deep emotional responses like shame or guilt, especially in cases of childhood trauma. Treatments like PE and EMDR are great for reducing classic PTSD symptoms, but they may not fully resolve these more complex emotional reactions. That’s where DBT-PTSD comes in, it's specifically designed to address both the core symptoms and these emotionally driven aspects of CPTSD.

Study Aims

The study had three aims: first, to measure whether emotions like shame, guilt, and disgust changed after treatment. Second, check if these changes were independent of improvements in PTSD symptoms. And third, to see how many participants reached emotion levels like those in people without PTSD.

Method

The intervention was an intensive, structured 3-month DBT-PTSD program delivered in a residential setting. It combined standard DBT elements—like emotion regulation and mindfulness—with trauma-specific techniques. One key feature was skills-assisted exposure, which helped prevent dissociation during trauma processing. The treatment also directly targeted negative self-beliefs and worked toward helping participants accept their traumatic experiences as part of their past, not their identity.

Participants

It's important to note that this was a relatively small and specific sample—mostly women with PTSD related to childhood abuse, and many had additional diagnoses like depression or borderline personality disorder (BPD). This makes the sample clinically relevant for complex PTSD, but it also limits how widely we can generalize the findings to other trauma populations.

Measures

To evaluate change, the researchers used simple but effective tools. Emotions were rated using 0–100 scales, asking participants how intensely they felt specific emotions when thinking about their trauma. PTSD symptoms were measured using the DTS, a well-established and reliable measure. Finally, they compared the participants' outcomes to a nonclinical reference group—people with similar trauma histories but without PTSD—to see if emotional levels normalized after treatment.

Analysis

The analysis was designed to test not just whether emotions changed, but whether those changes went beyond general PTSD improvement. By using MANOVA, the researchers could isolate the emotional shifts that weren’t simply side effects of PTSD symptom relief. They also used clinical significance benchmarks to see if participants reached emotional levels comparable to those without PTSD.

Results

The results showed significant improvements across most trauma-related emotions. By the end of treatment, a substantial proportion of participants reached nonclinical levels for these emotions, most notably, 76% for guilt and 69% for shame. These are very meaningful changes, especially considering the severity and persistence of these emotions in complex PTSD.

When we look at effect sizes, the largest improvements were seen in guilt, shame, fear, helplessness, and disgust. Interestingly, anger and sadness did not show significant change, which may suggest those emotions are either more complex or require different interventions.

Finally, radical acceptance—which is a core goal in DBT-PTSD—also increased significantly, with a large effect size. And it’s important to note that even after controlling PTSD symptom reduction, improvements in emotions like guilt and shame remained significant. That tells us this therapy doesn't just help with symptoms—it helps people emotionally process the trauma on a deeper level.

Discussion

This study highlights that DBT-PTSD has a distinct impact on trauma-related emotions, particularly guilt and shame—likely because it addresses them directly through exposure and cognitive work. Anger may be more complex, possibly serving an adaptive role in reframing blame. Radical acceptance improved, but for many, it remained a challenge. As for limitations, there was no active treatment control group, the sample was relatively small, and we don’t know if these gains were maintained long-term.

Cognitive Processing Therapy Versus Schema Therapy in the Treatment of PTSD among Military Veterans: Design of a Randomized Clinical Trial and Patient Preferences for Treatment

Amirpour, B., Badri, A., Aghayousefi, A., Alipour, A., & Zare, H. (2017). The effect of       cognitive processing therapy and schema therapy on marital satisfaction and avoidant coping in war veterans with chronic post-traumatic stress disorder. Journal of Nursing and Midwifery Sciences, 4(2), 1–10. http://jnms.mazums.ac.ir/article-1-121-en.html

Summary by: Alara Dogan

Introduction

Post-traumatic stress disorder (PTSD) does not impact only the internal state of the individual—it pervades the quality of their most intimate relationships, weakening emotional connections and instating patterns of avoidance. This pattern can especially be seen among veterans, whose combat-related trauma frequently presents as a disruptive subcurrent in their interpersonal lives. Amirpour et al. (2017) aimed to test whether two trauma-sensitive psychotherapies, Cognitive Processing Therapy (CPT) and Schema Therapy (ST)’ had a positive impact upon veterans with chronic PTSD, enhancing marital satisfaction and diminishing avoidant coping. While CPT is formalized and trauma-based, ST addresses more generalized early maladaptive schemas and overall psychological functioning. The central research question was clinically pertinent as much as it was humane in its scope: can we heal relational breaks by addressing the origins of trauma?

 

Methods

This semi-experiment involved 34 male Iran-Iraq war veterans from Kermanshah. Participants were initially screened with the Structured Clinical Interview for DSM-IV-TR Axis I Disorders, then required to have met criteria for PCL-M-PTSD (Post-Traumatic Stress Disorder Checklist—Military Version). Following exclusion, veterans were assigned randomly to three groups: CPT (n = 10), ST (n = 12), and a control (n = 12) group. The interventions involved group delivery, CPT in 12 sessions with a formal structure, ST being a modification of Young’s schema style. Outcomes were measured with GRIMS (Generalized Responsibility Inventory for Marital Satisfaction) for marital satisfaction, as well as with escape-avoidance subscale Coping Styles Questionnaire. Repeated-measures ANOVA was conducted in SPSS version 22, which monitored intra-group variance assumptions as well as group-time interactions.

 

Results

ST, as well as CPT, obviously surpassed the control group in both increasing marital satisfaction (p < .05) and decreasing avoidance coping strategies. Yet, CPT resulted in greater, more persistent decreases in avoidance symptoms, with post-test scores along with follow-up avoidance scores consistently showing improvement. ST, too, evidenced a short-term gain in marital satisfaction, but these gains faded over time. Demographic factors like age, wartime participation, as well as percentage of disability, remained evenly balanced, making findings more dependable.

 

Discussion

These findings align with clinical experience: directly engaging with the trauma, as CPT does, seems more to break up avoidance processes than more global interventions. The use of written exposure, along with cognitive reframing in CPT, perhaps allowed participants to engage with and reframe trauma memories, to decrease emotional numbing, and to bolster coping. Alternatively, ST’s overall emphasis upon schemas should increase short-term interpersonal understanding but should not adequately challenge avoidant behavior specific to trauma.

 

What I found most interesting in this research was its emphasis on relational outcomes, coping style, as well as marital satisfaction, over symptom severity. These are concerns that most often bring clients into treatment, but they have not been adequately represented in research. The conclusions indicate that CPT can lead to more stable relational gains by directly confronting avoidance, a fundamental aspect of PTSD.

 

Limitations

There are, naturally, some limitations to bear in mind. The all-male, combat exposed sample limits the generalizability. Group-based formats also might not generalize to comparable gains in individual contexts, and statistical significance found might not represent fully appreciable, clinically meaningful change for everyone. The research design didn't account for lifetime histories of trauma exposure or for prior psychiatric illness that can influence responsiveness to treatment.